SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA): SURAKSHA 52 Week High Streak: Second Straight Session Near Peak

SURAKSHA 52 Week High Streak has now held for a second straight session, with the stock trading within 2% of its one-year peak across both sessions. The latest reading places the share price at Rs 353.3, while the cumulative move across the streak stands at 1.68%. The latest Univest figures confirm the repeated near-high pattern, but they do not establish a company-specific catalyst for the continued move.

As of 30 September 2026 at 10:22 AM IST, SURAKSHA last traded at Rs 353.3 versus a previous close of Rs 355.3, after opening at Rs 355 and touching a low of Rs 350. The stock’s market capitalisation stands at Rs 1,809.55 crore. For readers, a repeated near 52-week high pattern is different from a single-day move because it shows persistence around the yearly peak rather than one isolated print.

SURAKSHA 52 Week High Streak: Consecutive High Analysis

Metric	Value
Current Price	Rs 353.3
Previous Close	Rs 355.3
Today's Move	Rs -2 (-0.56%)
Open	Rs 355
High	Rs 355.15
Low	Rs 350
Market Capitalisation	Rs 1,809.55 crore

SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) traded at Rs 353.3 versus the previous close of Rs 355.3, a fall of 0.56%. The stock opened at Rs 355, reached a high of Rs 355.15 and touched a low of Rs 350.

SURAKSHA share price today shows a mild pullback from the previous close, with the stock last traded at Rs 353.3 after a change of Rs -2, or -0.56%. It opened at Rs 355 and moved between Rs 350 and Rs 355.15 during the trading window captured at 30 September 2026 at 10:22 AM IST. That places the current price close to the upper end of the day’s range, even though it is below the previous close. The market capitalisation of Rs 1,809.55 crore helps frame the stock within the healthcare space, while the near-high streak keeps it in the “Stocks At One Year High Today” conversation. For SURAKSHA share price readers, the key point is not only today’s change but the fact that SURAKSHA 52 Week High Streak has persisted for a second straight session. The pattern keeps SURAKSHA in the spotlight of stock news searches and share price update queries, but it does not by itself explain why the share price has stayed near the yearly peak.

What the Repeated 52-Week Highs Show

The repeated high pattern shows that SURAKSHA 52 Week High Streak is not just a one-off event. SURAKSHA has traded within 2% of its 52-week high for a second straight session, and that makes the move more relevant for readers tracking 52 Week High Stocks and Stocks Hitting 52 Week Highs. The cumulative streak move of 1.68% is modest, which is important because it separates the streak from a sharp single-session jump. It tells readers that the stock has remained close to its yearly peak rather than making a large leap away from it. The latest Univest figures confirm the price pattern, but they do not confirm a company-specific reason behind it. In practical terms, SURAKSHA Consecutive 52 Week Highs are a signal to track the share price closely, especially when the stock is already trading near the upper end of its recent range.

For investors and traders following SURAKSHA New One Year High searches, the repeated pattern matters because it suggests continuity in market interest around the stock price, without making any claim about the cause. The key observation is simple: SURAKSHA Back To Back 52 Week Highs have now appeared across two sessions, and the stock remains near the 52-week peak rather than drifting far away from it.

SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,809.55 crore
P/E Ratio	51.69x
P/B Ratio	7.21x
ROE	13.81%
ROCE	24.97%
EPS	Rs 6.87
Book Value Per Share	Rs 49.28
Dividend Yield	0.14%

SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) fundamental metrics show P/E 51.69x, P/B 7.21x, ROE 13.81%, ROCE 24.97%. These figures provide context only and are not a buy or sell signal.

SURAKSHA DIAGNOSTIC LIMITED has a market capitalisation of Rs 1809.55 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 51.69x, P/B at 7.21x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 13.81% and ROCE of 24.97%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 6.87, book value per share of Rs 49.28, dividend yield of 0.14%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 42.95x, median ROE of 12.88%, median ROCE of 15.77%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	51.69x
Benchmark Median P/E	42.95x
Benchmark Average P/E	89.83x
Benchmark P/E Range	0x to 1,572.9x
Company P/B Ratio	7.21x
Benchmark Median P/B	3.76x
Company ROE	13.81%
Benchmark Median ROE	12.88%
Company ROCE	24.97%
Benchmark Median ROCE	15.77%
Company Market Capitalisation	Rs 1,809.55 crore
Benchmark Median Market Cap	Rs 533.06 crore

SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.

SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) has a P/E ratio of 51.69x, which is above the benchmark median of 42.95x, a difference of +20.35%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) has a ROE of 13.81%, which is above the benchmark median of 12.88%, a difference of +7.22%. SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) has a ROCE of 24.97%, which is above the benchmark median of 15.77%, a difference of +58.34%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Krsnaa Diagnostics Ltd.	KRSNAA	1,737.25	18.47	1.82	10.97	13.08
Shalby Ltd.	SHALBY	1,549.4	39.03	1.51	3.48	6.88
GUJARAT KIDNEY N SUP SP L	GKSL	1,371.48	88.1	5.41	12.08	15.51
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,498.57	32.78	6.76	25.22	29.21
GPT Healthcare Ltd.	GPTHEALTH	1,280.47	26.74	4.48	16.32	23.06

SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) has a P/E ratio of 51.69x compared with the displayed peer median of 32.78x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 13.81% compares with a peer median of 12.08% across the companies shown in the table. ROCE stood at 24.97% versus the displayed peer median of 15.51%, providing a capital-efficiency comparison. SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) has a market capitalisation of Rs 1,809.55 crore. Among the 5 peers shown, 1 has a larger market capitalisation.

Why Investors Are Watching SURAKSHA

• SURAKSHA 52 Week High Streak has held for a second straight session, keeping the share price near the yearly peak.
• The cumulative streak move stands at 1.68%, which helps separate this pattern from a one-session price jump.
• SURAKSHA share price is trading at Rs 353.3, close to the upper end of the day’s range.
• The company’s P/E ratio of 51.69 and P/B ratio of 7.21 place it above the industry median on valuation.
• ROE of 13.81% and ROCE of 24.97% provide a useful fundamental backdrop for SURAKSHA stock analysis.

About SURAKSHA DIAGNOSTIC LIMITED

SURAKSHA DIAGNOSTIC LIMITED operates in the healthcare space under the Hospital & Healthcare Services industry. The company’s share price, market cap and valuation metrics place it among the closely tracked healthcare names in the latest Univest data set. For readers following SURAKSHA Stock News, the key watchpoints are the company’s market capitalisation, earnings quality indicators such as EPS and book value, and return ratios including ROE and ROCE. The stock’s repeated proximity to its 52-week high has added another layer of interest to SURAKSHA share price discussions.

What does SURAKSHA 52 Week High Streak mean?

It means SURAKSHA has traded within 2% of its 52-week high for a second straight session. The pattern shows repeated proximity to the yearly peak, which is why it appears in stock news and share price searches.

Is SURAKSHA at a new 52-week high today?

No. The latest reading shows the stock is trading near its 52-week high, not necessarily setting a fresh peak in the current session. The key point is the repeated closeness over consecutive sessions.

What is the cumulative move in the SURAKSHA 52 Week High Streak?

The cumulative move across the streak is 1.68%. That figure captures the full movement across the consecutive sessions in which the stock stayed within 2% of its one-year high.

What is the latest SURAKSHA share price?

SURAKSHA last traded at Rs 353.3 as of 30 September 2026 at 10:22 AM IST. The stock was slightly below the previous close of Rs 355.3 at the time captured.

Why are investors watching SURAKSHA stock now?

Investors are watching the repeated near-high pattern, the premium valuation, and the company’s return ratios. Those factors together make SURAKSHA a closely tracked name among 52 Week High Stocks and healthcare shares.

Is SURAKSHA expensive on valuation?

Based on the latest figures, SURAKSHA trades at a P/E of 51.69 and a P/B of 7.21, both above the industry median in the same healthcare peer set. That places it on the higher side of valuation comparisons.

How does SURAKSHA compare with healthcare peers?

SURAKSHA is valued above several peers on P/E and P/B, while its ROE and ROCE are above the industry median. That mix makes it a different kind of healthcare share price story from lower-multiple peers.

What should readers monitor next in SURAKSHA stock analysis?

Readers should monitor whether the stock continues to trade near its 52-week peak, whether the streak extends, and how valuation compares with sector and peer benchmarks. The latest pattern is clear, while the company-specific driver remains unconfirmed.

Track SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) Share Price on Univest

Use SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.